Protagonist Therapeutics, Inc (PTGX)

Last Three Months

19-Jan-24 -- 18-Apr-24

Time Period:

Three Months
|
Year

($1.25M) Net Amount

Buy:	0	--
Sell:	($1.25M)	$30.69 - $31.62

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Buy

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

2

(2)

0

(1)

14

0

1

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Mar-24 8:00 PM View:	07-Mar-24 Option Exercise $12.27K	Selick Harold E Director		Protagonist Therapeutics, Inc - PTGX	30% 21.51K to 28.0K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 8:45 PM View:	01-Mar-24 Planned Option Sale ($406.64K)	Waddill William D. Director		Protagonist Therapeutics, Inc - PTGX	0% 12.0K	0	0	--	--	Show Txns Hide Txns

28-Feb-24 8:00 PM View:	26-Feb-24 Payment of Exercise ($126.45K)	Gupta Suneel Chief Development Officer		Protagonist Therapeutics, Inc - PTGX	(2%) 187.57K to 183.28K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 8:45 PM View:	01-Mar-24 Sale ($392.88K)	Ali Asif Chief Financial Officer		Protagonist Therapeutics, Inc - PTGX	(24%) 50.58K to 38.4K	0	($305.05K) (20%)	--	$30.69	Show Txns Hide Txns

02-Apr-24 8:29 PM View:	01-Apr-24 Sale (Planned) ($707.75K)	Patel Dinesh V Ph D President and CEO Director		Protagonist Therapeutics, Inc - PTGX	(11%) 619.22K to 549.59K	0	($948.60K) (5%)	--	$31.62	Show Txns Hide Txns